Batavia Biosciences receives $2.2 million follow-up grant from PATH to support new tools for polio eradication era

NEXT STORY
Aravive Announces Independent Data Monitoring Committee Recommends Continuation of Phase Ib Study of AVB-500 In Recurrent Platinum Resistant Ovarian Cancer After Review of First Two Cohorts of Patients
PREV STORY
Breast Cancer Therapeutics Market to Exhibit 10.2% CAGR, Increasing R&D Investment to Boost Growth, says Fortune Business Insights
Subscribe now to PM360
Get in touch with PM360 Experts On Call

Experts on Call

Ads

You May Also Like

Innovation Pharmaceuticals Announces Publication of Independent Research on Kevetrin, the Company’s p53 Drug Candidate, in Oncology Reports

author_avatar
NASDAQ Market News

AIM ImmunoTech Provides an Update on Its Pending Phase 2a Human Challenge Trial Using its Drug Ampligen

author_avatar
NASDAQ Market News

BeiGene Announces Clinical Results of Zanubrutinib in Mantle Cell Lymphoma From Two Presentations at the 60th American Society of Hematology Annual Meeting

Company to Host Investor Meeting and Webcast on Monday, December 3, at 8 pm ...

author_avatar
NASDAQ Market News